We are live on ! Find out more
CC

Cannell & Co Portfolio holdings

AUM $3.15B
1-Year Est. Return 30.62%
This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+30.62%
3 Year Est. Return
+51.59%
5 Year Est. Return
+187.25%
10 Year Est. Return
+311.51%
AUM
$2.67B
AUM Growth
+$18.9M
Cap. Flow
-$35.6M
Cap. Flow %
-1.33%
Top 10 Hldgs %
26.01%
Holding
264
New
17
Increased
48
Reduced
110
Closed
9

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$50.3M
2
LEN icon
Lennar Class A
LEN
+$45.6M
3
AL
Air Lease Corp
AL
+$34.3M
4
DIS icon
Walt Disney
DIS
+$10.5M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$9.93M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$38.5M
2
KKR icon
KKR & Co
KKR
+$33.1M
3
SPR
Spirit AeroSystems
SPR
+$24.9M
4
CB icon
Chubb
CB
+$21.5M
5
MU icon
Micron Technology
MU
+$16.1M

Sector Composition

Rank Sector Weight
1 Healthcare 17.97%
2 Technology 17.91%
3 Industrials 13.94%
4 Consumer Discretionary 11.86%
5 Financials 10.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLB icon
51
SLB Ltd
SLB
$77.8B
$17.1M 0.64%
254,695
-7,587
-3% -$521K
MRK icon
52
Merck
MRK
$324B
$16.9M 0.63%
292,334
+65,683
+29% +$3.71M
VAR
53
DELISTED
Varian Medical Systems, Inc.
VAR
$16.7M 0.62%
146,877
-2,450
-2% -$293K
MDLZ icon
54
Mondelez International
MDLZ
$77.7B
$16.3M 0.61%
397,039
+22,765
+6% +$915K
COST icon
55
Costco
COST
$415B
$15.8M 0.59%
75,682
-150
-0.2% -$29.6K
KMB icon
56
Kimberly-Clark
KMB
$36.4B
$15.6M 0.58%
147,636
NKE icon
57
Nike
NKE
$61.9B
$15.4M 0.58%
193,010
-201,110
-51% -$14.2M
INTC icon
58
Intel
INTC
$466B
$14.3M 0.53%
287,685
-2,100
-0.7% -$112K
KO icon
59
Coca-Cola
KO
$354B
$13.6M 0.51%
309,521
-681
-0.2% -$29.4K
BALL icon
60
Ball Corp
BALL
$17B
$13M 0.49%
365,785
+35,203
+11% +$1.35M
KMX icon
61
CarMax
KMX
$8.27B
$12.7M 0.47%
174,248
-275
-0.2% -$18.4K
DHR icon
62
Danaher
DHR
$135B
$12.5M 0.47%
142,731
-339
-0.2% -$30.2K
ADP icon
63
Automatic Data Processing
ADP
$100B
$12.1M 0.45%
90,488
+852
+1% +$108K
FNF icon
64
Fidelity National Financial
FNF
$13.9B
$12.1M 0.45%
334,381
-3,172
-0.9% -$116K
CVX icon
65
Chevron
CVX
$388B
$12.1M 0.45%
95,531
+41,725
+78% +$5.18M
PFE icon
66
Pfizer
PFE
$140B
$11.8M 0.44%
343,565
-2,271
-0.7% -$77.6K
ESRX
67
DELISTED
Express Scripts Holding Company
ESRX
$11.6M 0.44%
150,770
-2,275
-1% -$171K
GOOGL icon
68
Alphabet (Google) Class A
GOOGL
$3.91T
$11.6M 0.43%
204,980
+2,960
+1% +$161K
REGN icon
69
Regeneron Pharmaceuticals
REGN
$68.8B
$11.3M 0.42%
32,716
+31,736
+3,238% +$9.93M
PWR icon
70
Quanta Services
PWR
$93.9B
$10.8M 0.4%
324,200
+135,100
+71% +$4.73M
MU icon
71
Micron Technology
MU
$1.04T
$10.7M 0.4%
204,800
-298,030
-59% -$16.1M
HCA icon
72
HCA Healthcare
HCA
$84.8B
$10.5M 0.39%
101,858
-7,755
-7% -$785K
APU
73
DELISTED
AmeriGas Partners, L.P.
APU
$10.4M 0.39%
247,435
+1,640
+0.7% +$68.3K
SVU
74
DELISTED
SUPERVALU Inc.
SVU
$10.4M 0.39%
+504,850
New +$8.89M
GMLP
75
DELISTED
Golar LNG Partners LP
GMLP
$9.99M 0.37%
646,325
-84,925
-12% -$1.54M

Similar funds

Cannell & Co's Q2 2018 Portfolio in Review

As of Q2 2018, Cannell & Co held 264 positions worth $2.67B, up 0.71% from $2.66B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Cannell & Co's Q2 2018 filing shows 17 new, 48 increased, 110 reduced and 9 closed positions. Its largest new stake was Broadcom: 2,051,400 shares worth $49.8M. The largest sale was Celgene Corp, an estimated $38.5M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.

  • Cannell & Co's largest Q2 2018 buy was Broadcom: 2,051,400 shares worth $49.8M.
  • Cannell & Co added most to Lennar Class A in Q2 2018, an estimated $45.6M increase.
  • Cannell & Co's biggest Q2 2018 reduction was Celgene Corp, cutting an estimated $38.5M.
  • Cannell & Co fully exited KKR & Co in Q2 2018, selling an estimated $33.1M.
  • Cannell & Co's ten largest holdings make up 26% of its $2.67B portfolio in Q2 2018.
  • Cannell & Co opened 17 new positions and closed 9 in Q2 2018.
  • Cannell & Co's portfolio value rose 0.71% quarter-over-quarter to $2.67B.

Based on Cannell & Co's 13F filing for Q2 2018, filed 6 Aug 2018.